Juan Cantizani
-
- Research on Leishmaniasis Studies 8
-
- Trypanosoma species research and implications 9
-
- Microbial Natural Products and Biosynthesis 4
-
- Synthesis and Biological Evaluation 3
-
- Natural product bioactivities and synthesis 3
-
- Alzheimer's disease research and treatments 2
-
- Parkinson's Disease Mechanisms and Treatments 2
-
- Phytochemistry and Biological Activities 2
Juan Cantizani
24 papers receiving 422 citations
Peers
Comparison fields: 5 of 66
- Public Health, Environmental and Occupational Health 158
- Biotechnology 44
- Epidemiology 157
- Pharmacology 75
- Organic Chemistry 112
Countries citing papers authored by Juan Cantizani
This map shows the geographic impact of Juan Cantizani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Cantizani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Cantizani more than expected).
Fields of papers citing papers by Juan Cantizani
This network shows the impact of papers produced by Juan Cantizani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Cantizani. The network helps show where Juan Cantizani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Juan Cantizani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 4 | |
| 5 | 2021 | 7 | |
| 6 | 2020 | 18 | |
| 7 | 2019 | 13 | |
| 8 | 2018 | 22 | |
| 9 | 2018 | 20 | |
| 10 | 2017 | 3 | |
| 11 | 2016 | 2 | |
| 12 | 2016 | 30 | |
| 13 | 2015 | 11 | |
| 14 | 2015 | 49 | |
| 15 | 2015 | 13 | |
| 16 | Antiproliferative and apoptotic potential of Chinese medicinal plants against MCF-7 (luminal A), HCC1954 (HER2+) and Hs578t breast cancer cells | 2013 | 2 |
| 17 | Anti-proliferative activities of selected Chinese medicinal herbs against human cancer cell lines | 2013 | 4 |
| 18 | 2012 | 17 | |
| 19 | 2012 | 119 | |
| 20 | 2012 | 13 |
About Juan Cantizani
Juan Cantizani is a scholar working on Pharmacology, Epidemiology and Public Health, Environmental and Occupational Health, having authored 24 papers that have together received 424 indexed citations. Recurring topics across this work include Trypanosoma species research and implications (9 papers), Research on Leishmaniasis Studies (8 papers), Microbial Natural Products and Biosynthesis (4 papers), Natural product bioactivities and synthesis (3 papers), Synthesis and Biological Evaluation (3 papers), Alzheimer's disease research and treatments (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Phytochemistry and Biological Activities (2 papers). The work is most often cited by research in Public Health, Environmental and Occupational Health (158 citations), Biotechnology (44 citations) and Epidemiology (157 citations). Juan Cantizani has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Francisca Vicente, Olga Genilloud, Imanol Peña, José R. Tormo, Maria Cândida Monteiro, Ignacio Cotillo, J.J. Martin, Julio Martín, Mercedes de la Cruz and Vito Valiante. Their work appears in journals such as PLoS ONE, Scientific Reports and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.